Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Recall #: D-0649-2024
Affected scope: 44,208 containers
Initiated: August 1, 2024

Compiled from official public sources by the publisher. · Updated September 2026

Baxter Healthcare Corporation recalled Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 u… - a critical-severity action.

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 u… was recalled by Baxter Healthcare Corporation in September 11, 2024. Reason: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.. Check the official notice for the remedy. Verify recall #D-0649-2024 with the FDA Drug before acting.

The recall

Baxter Healthcare Corporation issued this critical-severity FDA Drug recall-Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing..

Critical
severity level: Class I
classification: September 11, 2024
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0649-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Reason for recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Critical (Class I)
Status	Ongoing
Recall number	D-0649-2024
Date reported	September 11, 2024
Date initiated	August 1, 2024
Recalling firm	Baxter Healthcare Corporation
Firm location	Round Lake, IL
Affected scope	44,208 containers
Distribution	Nationwide in the USA

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0649-2024) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04. Recalled by Baxter Healthcare Corporation. Units affected: 44,208 containers.

Why was this product recalled? ▼

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on September 11, 2024. Severity: Critical. Recall number: D-0649-2024.

Where was the recalled product distributed? ▼

Distribution: Nationwide in the USA.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Critical), closest by report date among other firms and states.

Butternut Squash Cubes - 12oz Plastic Cla… 2024-09-11 Chopped Cilantro with White Onion - 5oz P… 2024-09-11 Salsa Medium - 16 oz Salsa Mild - 16 oz … 2024-09-11 Pico de Gallo Classic Hot - 14 oz 639123… 2024-09-11

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Semaglutide, 2 mL (2.5mg/mL), Compounded … 2024-09-11 Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL,… 2024-09-11 SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2… 2024-09-11 SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Mul… 2024-09-11

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported September 11, 2024. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026